Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability
Name:
s13293-020-00289-5.pdf
Size:
1.737Mb
Format:
PDF
Description:
Final Published Version
Author
Rafikova, OlgaJames, Joel
Eccles, Cody A
Kurdyukov, Sergey
Niihori, Maki
Varghese, Mathews Valuparampil
Rafikov, Ruslan
Affiliation
Univ Arizona, Dept Med, Div EndocrinolIssue Date
2020-03-18Keywords
Endothelial barrier functionHeme signaling
Lung permeability
Pulmonary hypertension
Sex difference
Metadata
Show full item recordPublisher
BMCCitation
Rafikova, O., James, J., Eccles, C.A. et al. Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability. Biol Sex Differ 11, 11 (2020). https://doi.org/10.1186/s13293-020-00289-5Journal
BIOLOGY OF SEX DIFFERENCESRights
Copyright © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background The mechanisms involved in pulmonary hypertension (PH) development in patients and pre-clinical models are poorly understood. PH has a well-established sex dimorphism in patients with increased frequency of PH in females, and more severe disease with poor survival prognosis in males. Previously, we found that heme signaling plays an essential role in the development phase of the Sugen/Hypoxia (SU/Hx) model. This study is focused on the elucidation of sex differences in mechanisms of PH development related to heme action at the early stage of the monocrotaline (MCT) PH model. Methods Rats received MCT injection (60 mg/kg, i.p.) and followed for 14 days to investigate early disease changes. Hemodynamic parameters were recorded at the end of the study; plasma, lung homogenates, and nuclear fractions were used for the evaluation of protein levels. Results Our data indicate that on day 14, rats did not show any significant increase in the Fulton index due to the early disease phase. However, the right ventricular systolic pressure was significantly increased in male rats, while female rats showed only a trend. Interestingly, only males demonstrated an increased lung-to-bodyweight ratio that indicated lung edema. Indeed, lung histology confirmed severe perivascular edema in males. Previously, we have reported that the increased perivascular edema in SU/Hx model correlated with intravascular hemolysis and activated heme signaling. Here, we found that elevated free hemoglobin levels and perivascular edema were increased, specifically in males showing more rapid progress of PH. A high level of heme carrier protein 1 (HCP-1), which is involved in heme uptake from the bloodstream into the cells, was also found elevated in the lungs of males. The upregulation of heme oxygenase in males indicated increased intracellular heme catabolism. Increased heme signaling resulted in the activation of heme-mediated barrier-disruptive mechanisms. Thus, hemolysis in males can be responsible for increased permeability of the lungs and early disease development. Conclusions Our study indicates the importance of barrier-disruptive mechanisms as an earlier event in the induction of pulmonary hypertension. Importantly, males are more susceptible to hemolysis and develop PH earlier than females.Note
Open access journalISSN
2042-6410PubMed ID
32188512Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1186/s13293-020-00289-5
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Related articles
- Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.
- Authors: Rafikova O, Williams ER, McBride ML, Zemskova M, Srivastava A, Nair V, Desai AA, Langlais PR, Zemskov E, Simon M, Mandarino LJ, Rafikov R
- Issue date: 2018 Sep
- Increased pulmonary heme oxygenase-1 and delta-aminolevulinate synthase expression in monocrotaline-induced pulmonary hypertension.
- Authors: Iwasaki T, Takahashi T, Shimizu H, Ohmori E, Morimoto T, Kajiya M, Takeuchi M, Morita K, Akagi R, Kajiya F
- Issue date: 2005 Apr
- 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
- Authors: Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G
- Issue date: 2006 Dec
- Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
- Authors: Lan B, Hayama E, Kawaguchi N, Furutani Y, Nakanishi T
- Issue date: 2015
- Hemin treatment abrogates monocrotaline-induced pulmonary hypertension.
- Authors: Shimzu K, Takahashi T, Iwasaki T, Shimizu H, Inoue K, Morimatsu H, Omori E, Matsumi M, Akagi R, Morita K
- Issue date: 2008 Nov